Principal Financial Group’s Protagonist Therapeutics PTGX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$38.8M	Buy	367,822 +19,890	+6%	+$1.76M	0.02%	564
2025 Q4	$30.4M	Buy	347,932 +21,844	+7%	+$1.79M	0.02%	656
2025 Q3	$21.7M	Sell	326,088 -4,046	-1%	-$230K	0.01%	822
2025 Q2	$18.2M	Sell	330,134 -16,961	-5%	-$814K	0.01%	886
2025 Q1	$16.8M	Buy	347,095 +9,286	+3%	+$389K	0.01%	949
2024 Q4	$13M	Buy	337,809 +16,977	+5%	+$740K	0.01%	1134
2024 Q3	$14.4M	Buy	320,832 +310,804	+3,099%	+$12.6M	0.01%	1050
2024 Q2	$347K	Sell	10,028 -4,341	-30%	-$127K	﹤0.01%	2033
2024 Q1	$416K	Sell	14,369 -60	-0.4%	-$1.63K	﹤0.01%	2029
2023 Q4	$331K	Sell	14,429 -542	-4%	-$9.48K	﹤0.01%	2036
2023 Q3	$250K	Buy	14,971 +1,068	+8%	+$20.7K	﹤0.01%	2107
2023 Q2	$384K	Buy	13,903 +380	+3%	+$9.51K	﹤0.01%	2012
2023 Q1	$311K	Buy	13,523 +1,785	+15%	+$30K	﹤0.01%	2078
2022 Q4	$128K	Buy	11,738 +1,389	+13%	+$11.7K	﹤0.01%	2263
2022 Q3	$87K	Buy	+10,349	New	+$97.9K	﹤0.01%	2355
2022 Q1	–	Sell	-7,607	Closed	-$260K	–	2591
2021 Q4	$260K	Buy	+7,607	New	+$240K	﹤0.01%	2288
2021 Q3	–	Sell	-16,540	Closed	-$743K	–	2613
2021 Q2	$743K	Buy	16,540 +8,364	+102%	+$276K	﹤0.01%	2116
2021 Q1	$212K	Buy	+8,176	New	+$207K	﹤0.01%	2369